SR1001, RORalpha and RORgammat inverse agonist
Be the first to review this product! Submit a review
|
(1 Publication)
MW 477.4 Da, Purity >98%. Potent, selective RORα and RORγt inverse agonist (Ki values are 172 and 111 nM for RORα and RORγ respectively). Suppresses IL-17 promoter driven transcriptional activity. Inhibits TRAP220 nuclear receptor box 2 peptide interaction (IC50 = 117 nM). Shows immunosuppressant effects in vivo..
View Alternative Names
IMD42, MGC129539, NR1F1, NR1F3, Nuclear receptor ROR-alpha, Nuclear receptor ROR-gamma, Nuclear receptor RZR-alpha, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 1, Nuclear receptor subfamily 1 group F member 3, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor alpha, RAR related orphan receptor gamma, RAR-related orphan receptor A, RAR-related orphan receptor C, RORA_HUMAN, RORG_HUMAN, RZR GAMMA, RZR-ALPHA, RZRA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-alpha, Retinoid-related orphan receptor-gamma, Rorc, TOR, Transcription factor RZR alpha, fhl2a
- Chemical Structure
Lab
Chemical Structure - SR1001, RORalpha and RORgammat inverse agonist (AB141462)
2D chemical structure image of ab141462, SR1001, RORalpha and RORgammat inverse agonist
Product details
Properties and storage information
Shipped at conditions
Appropriate long-term storage conditions
Storage information
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 9:e20118 PubMed37809525
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com